More on our work in obesity care: To view or add a comment, sign in Diabetes management is not about numbers its about outcomes
In the SURMOUNT-1 trial, tirzepatide demonstrated weight loss of approximately 15-21% at 72 weeks, depending on dose
Effects on weight reduction and safety of short-term phentermine administration in Korean obese people, Yosei Medical Journal (2006) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Ozempic (semaglutide) injection prescribing information, Food and Drug Administration (2023) Phentermine hydrochloride tablets prescribing information, Food and Drug Administration (2017) Semaglutide, StatPearls (2024) Three- and six-month efficacy and safety of phentermine in a Mexican obese population, International Journal of Clinical Pharmacology and Therapeutics (2021) Topiramate and phentermine, StatPearls (2023) Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network Open (2022) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
About Weight Watchers Weight Watchers is the global leader in science-backed weight management, offering an integrated support system built for the GLP-1 era that combines scientific expertise, medication, cutting-edge technology, and human connection
For a full clinical dose of KSM-66 (600mg), the standalone product delivers more
Health conditions : Kidney disease or other conditions may require adjusted targets
